Showing 121-130 of 2878 results for "".
2015 Cosmetic Surgery Forum: Jeanine Downie, MD
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/2015-cosmetic-surgery-forum-jeanine-downie-md/18264/DermWireTV: Cosmetic Surgery Forum Highlights, LEO Focuses on AD
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-cosmetic-surgery-forum-highlights-leo-focuses-on-ad/19703/New treatments and medical controversies take center stage at Cosmetic Surgery Forum as the meeting moves to Nashville in its 11th Year. Leo Pharma’s tralokinumab meets all primary and secondary endpoints in three pivotal Phase 3 studies for the treatment of adults with moderate-to-severe atopic derTopical Toxins: Now and Later
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/topical-toxins-now-and-later/18768/Topical neurotoxins are in late-stage development, with the potential to offer "softer" results and reduction of fine wrinkles. But they may not be approved for another few years. In the meantime, micro channel delivery of toxins, such as with AquaGold, is an option. Joel Schlessinger, MD, founder oTop 2023 Psoriasis Treatment Announcements
https://practicaldermatology.com/topics/psoriasis/top-2023-psoriasis-treatment-announcements/20232/Daniel Schlessinger, MD, Mohs Micrographic Surgery and Cosmetic Dermatology Fellow at Northwestern University, reviews for Practical Dermatology® some of the important psoriasis drug approval news of 2023.The Importance of Keeping Up with New Developments
https://practicaldermatology.com/conferences/maui-derm-2024/the-importance-of-keeping-up-with-new-developments/20257/Practical Dermatology® Chief Medical Editor Neal Bhatia, MD, chats with Resident Of Distinction Award-winner Dawn Queen, MD, at Maui Derm 2024, about the critical role of continuing to educate yourself as a practitioner, and the importance of keeping on top of new drugs and therapies in daily practiWhat are Dermatologists’ Obstacles to Buy and Bill?
https://practicaldermatology.com/conferences/maui-derm-2024/what-are-dermatologists-obstacles-to-buy-and-bill/20241/Challenges with fee schedules have prompted many dermatologists to consider the buy and bill model. In a conversation between Practical Dermatology’s Chief Medical Editor Neal Bhatia, MD and Mark Kaufmann, MD, associate clinical professor at Mount Sinai, the doctors discuss some of the opportunitiesPortfolio Management
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/portfolio-management/19702/Develop and use a portfolio of options to treat facial aesthetic concerns, urges Joel L. Cohen, MD as he talks about injectables, devices, and topicals for use in the cosmetic practice today.Cosmetics Challenge
https://practicaldermatology.com/topics/general-topics/cosmetics-challenge/21793/Chemoprevention Strategies for AK Patients
https://practicaldermatology.com/topics/skin-cancer-photoprotection/chemoprevention-strategies-for-ak-patients/18822/Neal Bhatia, MD, Chief Medical Editor of Practical Dermatology®, provides strategies for treating actinic keratoses, as well as for prevention and management. He discusses the importance of sun protection and photodamage prevention, and says the key to treatment and maintenance is combination therapTherapeutics Update: Exploring Current Treatments for Diverse Conditions
https://practicaldermatology.com/topics/therapeutics-update/therapeutics-update-exploring-current-treatments-diverse-conditions/24562/Chief Medical Editor Neal Bhatia, MD, FAAD, and the Practical Dermatology® team convened an expert roundtable to discuss therapeutic treatment strategies for vitiligo, alopecia areata, hidradenitis suppurativa, and chronic spontaneous urticaria—the latest options, what has fallen out of favor, chall